Envisage report cover

Contract Research Organizations Market - By Type (Discovery, CMC, Preclinical, Clinical Research, and Laboratory Services), By Therapeutic Area (CNS, Oncology, and Cardiovascular), By End-User (Pharmaceuticals & Medical Device), and By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) - Industry Analysis, opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 193

Status: Published

Report Code: ARI100327

The Global Contract Research Organizations Market is expected to grow from USD 43.9 billion in 2020 to USD 74.50 billion by 2027 at a CAGR of 7.80%. An increasing number of clinical trials, an increase in the number of outsourcing of R&D activities, expanding the scope of CRO solutions through technology, increasing, and favourable regulatory environments in the developed regions, investments in research and development and increasing strategic collaborations among market players are the major factors driving the growth of the CRO services market. Moreover, growth in the past resulted from increased patent expirations of drugs, rising costs of drug development, and growth in the biologics market. In addition, the CRO market is being driven by the biopharmaceutical industry’s improving fundamentals. The contract research organization market can be restrained by structural changes in industry and employment, the high cost of labour, exchange rate volatility, a flight of contract research to developing regions, and others.

A Contract Research Organisation, also called Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services (for both drugs and medical devices). CROs range from large, international full-service organizations to small, niche speciality groups and can offer their clients the experience of moving a new drug or device from its conception to FDA marketing approval without the drug sponsor having to maintain a staff for these services. Organizations and businesses that contract with CROs do so to acquire specific expertise without hiring permanent staff. Some CROs manage almost all aspects of a clinical trial, from site selection and patient enrolment through final regulatory approval from the Food and Drug Administration and European Medicines Agency.

Multi-location trials of a single drug in different procedures in different countries pose a challenge to pharmaceutical companies as they have to follow a completely different procedure in each country. This is observed as one of the major challenges for research outsourcing in different countries and so, a company prefers to restrict outsourcing to one destination country. This restricts the research outsourcing market on a global level. Some of the key players operating in contract research organization market are IQVIA, Clinipace, Charles River Laboratories International, CMIC Holdings, Medpace, Parexel International, EPS International, ICON, PRA Health Sciences and Synteract. These market players are strategically implementing different approaches to garner a higher market share.

Analysts Commentary:
The growing demand of effective drugs and healthcare devices, high cost of product development, and growing patient population are some of the factors that are likely to boost the global CRO services market growth during the forecast period. Additionally, stringent drug approval process and growing strategic collaboration among many key players are also likely to propel the CRO services market revenue during the forecast period.

In May 2019, Altasciences formed a collaboration with WuXi AppTec to support the full scope of drug development programs, from IND-enabling studies to regulatory support for both pre-IND and post-IND stages, as well as document preparation and submission provided by WuXi AppTec’s Investigational New Drug (WIND) platform. In 2019, Laboratory Corporation of America Holdings, invested $485 Mn to purchase the Envigo nonclinical contract research organization services business to expand the global research capabilities of Covance’s nonclinical drug development business segment.

Segmentation:
The global contract research organization market is segmented into type, therapeutic area, end-user, and region. Based on type, the market is further categorised into Discovery, CMC, Preclinical, Clinical Research, and Laboratory Services. clinical research services segment accounted for the largest share of the global CRO services market. This could be owing to factors such as the growing biosimilar and biologics markets, increased R&D investments in pharmaceutical and biopharmaceutical companies, and an increase in clinical trial activities. Based on Therapeutics area, the market can be divided into CNS, Oncology, and Cardiovascular. the oncology segment accounted for the highest growth in this market. The highest growth rate of this segment is due to the increase in number of clinical trials and a rising prevalence of cancer worldwide.

Based on end-user, the market is segregated into Pharmaceuticals & Medical Device. The medical device segment is expected to show the highest CAGR during the forecast period. Technological advancements in medical devices, increasing incidence of chronic diseases, and the adoption of point-of-care (POC) testing are the major factors supporting the growth of this segment.

Regional Analysis:

The CRO market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America dominates the CRO market owing to a well-developed healthcare sector and huge investment. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in North America. Moreover, the presence of developed economies like the U.S. and Canada within the region will boost market growth. Europe is the second-largest global contract research organization market, which is followed by the Asia Pacific. Regionally, Europe is divided into Western Europe and Eastern Europe. Western Europe holds the major share of the regional market, which is majorly contributed by Germany, the U.K., and France. However, Eastern Europe is the fastest-growing region due to the huge opportunities in the untapped market.

Asia Pacific CRO market will show over 8.5% CAGR owing to increasing outsourcing by pharmaceutical and biotechnology companies. Regional growth can be attributed to strong the foothold of foremost pharma and biopharma companies along with rising R&D investments. Moreover, improving trend of outsourcing research activities to countries such as India and China due to lower costs and the presence of capable healthcare professionals should enhance the regional growth. The Middle East & Africa owing to the growing burden of various chronic disease and rising awareness about the treatment benefits associated with the low-cost clinical tutorial, the design has enhanced the participation of many patients in clinical trial research activities which will fuel the global contract research organization services market growth during the forecast period.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Contract Research Organizations Market
Chapter 5. Global Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
5.1. Global Contract Research Organizations Market Share, By Type, 2015 - 2027 (Volume/Units) (USD Million)
5.1.1. Discovery
5.1.1.1. Market Size and Projections,2015 - 2027 (Volume/Units) (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (Volume/Units) (USD Million)
5.1.2. CMC
5.1.2.1. Market Size and Projections, 2015 - 2027 (Volume/Units) (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (Volume/Units) (USD Million)
5.1.3. Preclinical
5.1.3.1. Market Size and Projections, 2015 - 2027 (Volume/Units) (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (Volume/Units) (USD Million)
5.1.4. Clinical Research
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.5. Laboratory Services
5.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (Volume/Units) (USD Million)
6.1. Global Contract Research Organizations Share, By Therapeutics area, 2015 - 2027 (Volume/Units) (USD Million)
6.1.1. CNS
6.1.1.1. Market Size and projections,2015 - 2027 (Volume/Units) (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Oncology
6.1.2.1. Market Size and projections,2015 – 2027 (Volume/Units) (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 Market Size and Projections, by Region, 2015 - 2027 (USD Million) (USD Million)
6.1.3. Cardiovascular
6.1.3.1. Market Size and projections,2015 – 2027 (Volume/Units) (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 Market Size and Projections, by Region, 2015 - 2027 (USD Million) (USD Million)
Chapter 7. Global Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
7.1. Global Contract Research Organizations Share, By End-user, 2015 - 2027 (USD Million)
7.1.1. Pharmaceuticals
7.1.1.1. Market Size and projections,2015 - 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Medical Device
7.1.2.1. Market Size and projections,2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Contract Research Organizations Market Overview, By Geography, 2015 - 2027 (Volume/Units) (USD Million)
8.1. Global Contract Research Organizations Market Share, By Geography, 2015 - 2027 (Volume/Units) (USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2027 (Volume/Units) (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2018 (%)
Chapter 9. North America Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (Volume/Units) (USD Million)
9.1. North America Contract Research Organizations Market Overview, 2015 - 2027 (Volume/Units) (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
9.1.2. North America Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
9.1.3. North America Contract Research Organizations Market Overview, By Therapeutics areas,2015 - 2027 (Volume/Units) (USD Million)
9.1.4. North America Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.1. U.S. Contract Research Organizations Market Overview, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.1.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.1.2. U.S. Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.1.3. U.S. Contract Research Organizations Market Overview, By Therapeutics area,2015 - 2027 (Volume/Units) (USD Million)
9.1.4.1.4. U.S. Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.2. Canada Contract Research Organizations Market Overview, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.2.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.2.2. Canada Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.2.3. Canada Contract Research Organizations Market Overview, By Therapeutics area,2015 - 2027 (Volume/Units) (USD Million)
9.1.4.2.4. Canada Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.3. Mexico Contract Research Organizations Market Overview, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.3.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.3.2. Mexico Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
9.1.4.3.3. Mexico Contract Research Organizations Market Overview, By Therapeutics area,2015 - 2027 (Volume/Units) (USD Million)
9.1.4.3.4. Mexico Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
Chapter 10. Europe Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (Volume/Units) (USD Million)
10.1. Europe Contract Research Organizations Market Overview, 2015 - 2027 (Volume/Units) (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
10.1.2. Europe Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3. Europe Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.1. Germany
10.1.3.1.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.1.2. Germany Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.1.3. Germany Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.1.4. Germany Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.2. France
10.1.3.2.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.2.2. France Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.2.3. France Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.2.4. France Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.3. UK
10.1.3.3.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.3.2. UK Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.3.3. UK Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.3.4. UK Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.4. Italy
10.1.3.4.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.4.2. Italy Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.4.3. Italy Contract Research Organizations Market Overview, By Therapeutics area 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.4.4. Italy Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.5. Spain
10.1.3.5.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.5.2. Spain Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.5.3. Spain Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.5.4. Spain Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.6. Rest of Europe
10.1.3.6.1. Market size and projections, 2015 – 2025
10.1.3.6.2. Rest of Europe Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.6.3. Rest of Europe Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (Volume/Units) (USD Million)
10.1.3.6.4. Rest of Europe Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
Chapter 11. Asia Pacific Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Contract Research Organizations Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. India
11.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. India Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.1.3. India Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
11.1.4.1.4. India Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
11.1.4.2. China
11.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. China Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.2.3. China Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
11.1.4.2.4. China Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
11.1.4.3. Japan
11.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Japan Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.3.3. Japan Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
11.1.4.3.4. Japan Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
11.1.4.4. South Korea
11.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.4.2. South Korea Contract Research Organizations Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
11.1.4.4.3. South Korea Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
11.1.4.4.4. South Korea Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
11.1.4.5. Rest of Asia Pacific
11.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.5.2. Rest of Asia Pacific Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.5.3. Rest of Asia Pacific Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
11.1.4.5.4. Rest of Asia Pacific Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
Chapter 12. Middle East & Africa Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Contract Research Organizations Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.4.1. GCC
12.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.1.2. GCC Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.1.3. GCC Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
12.1.4.1.4. GCC Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
12.1.4.2. South Africa
12.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.2.2. South Africa Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.2.3. South Africa Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
12.1.4.2.4. South Africa Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
12.1.4.3. Rest of Middle East & Africa
12.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.3.2. Rest of Middle East & Africa Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.3.3. Rest of Middle East & Africa Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
12.1.4.3.4. Rest of Middle East & Africa Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
Chapter 13. South America Contract Research Organizations Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Contract Research Organizations Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.2. South America Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.3. South America Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
13.1.4. South America Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
13.1.5. South America Contract Research Organizations Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.6.2. Brazil Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.6.3. Brazil Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
13.1.6.4. Brazil Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
13.1.7. Argentina
13.1.7.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.7.2. Argentina Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.7.3. Argentina Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
13.1.7.4. Argentina Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
13.1.8. Rest of South America
13.1.8.1. Market size and projections, 2015 – 2026
13.1.8.2. Rest of South America Contract Research Organizations Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.8.3. Rest of South America Contract Research Organizations Market Overview, By Therapeutics area, 2015 - 2027 (USD Million)
13.1.8.4. Rest of South America Contract Research Organizations Market Overview, By End User, 2015 - 2027 (Volume/Units) (USD Million)
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New product development
Chapter 15. Key Vendor Analysis
15.1. IQVIA.
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Clinipace.
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Charles River Laboratories International
15.4. CMIC Holdings
15.5. Medpace
15.6. Parexel International
15.7. EPS International
15.8. ICON.
15.9. PRA Health Sciences
15.10. Synteract
15.11. SIA Engineering company Ltd
Chapter 16. Contract Research Organizations Market Cost Analysis
16.1. Contract Research Organizations Market Key Raw Materials Analysis
16.1.1. Key Raw Materials
16.1.2. Price Trend of Key Raw Materials
16.1.3. Key Suppliers of Raw Materials
16.1.4. Market Concentration Rate of Raw Materials
16.2. Proportion of Wing Cost Structure
16.2.1. Raw Materials
16.2.2. Labor Cost
16.2.3. Wing Expenses
16.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 17. CNS Chain, Sourcing Strategy and Downstream Buyers
17.1. Contract Research Organizations Market CNS Chain Analysis
17.2. Upstream Raw Materials Sourcing
17.3. Raw Materials Sources of Contract Research Organizations Market Major Manufacturers in 2019
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Type Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Type Progress in Related Industry
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Contract Research Organizations Market share, by Type, 2020 & 2027 (%)
10. Global Contract Research Organizations Market share, by Discovery, by Type, 2020 & 2027 (USD Million)
11. Global Contract Research Organizations Market share, by CMC, by Type 2020 & 2027 (USD Million)
12. Global Contract Research Organizations Market share, by Therapeutics area, 2020 & 2027 (%)
13. Global Contract Research Organizations Market share, by CNS, by Therapeutics area, 2020 & 2027 (USD Million)
14. Global Contract Research Organizations Market share, by Oncology, by Therapeutics area, 2020 & 2027 (USD Million)
15. Global Contract Research Organizations Market share, by region, 2020 & 2027 (%)
16. Global Contract Research Organizations Market share, by region, 2020 - 2027(USD Million)
17. North America Contract Research Organizations Market, 2020 - 2027(USD Million)
18. North America Contract Research Organizations Market share, by Countries, 2020 & 2027 (%)
19. U.S. Contract Research Organizations Market, 2020 - 2027(USD Million)
20. Canada Contract Research Organizations Market, 2020 - 2027(USD Million)
21. Europe Contract Research Organizations Market, 2020 - 2027(USD Million)
22. Europe Contract Research Organizations Market share, by Countries, 2020 & 2027 (%)
23. Spain Contract Research Organizations Market, 2020 - 2027(USD Million)
24. UK Contract Research Organizations Market, 2020 - 2027(USD Million)
25. Italy Contract Research Organizations Market, 2020 - 2027(USD Million)
26. Germany Contract Research Organizations Market, 2020 - 2027(USD Million)
27. France Contract Research Organizations Market, 2020 - 2027(USD Million)
28. Rest of Europe Contract Research Organizations Market, 2020 - 2027(USD Million)
29. Asia-Pacific Contract Research Organizations Market, 2020 - 2027(USD Million)
30. Asia-Pacific Contract Research Organizations Market share, by Countries, 2020 & 2027 (%) China Contract Research Organizations Market, 2020 - 2027(USD Million)
31. India Contract Research Organizations Market, 2020 - 2027(USD Million)
32. Australia Contract Research Organizations Market, 2020 - 2027(USD Million)
33. Japan Contract Research Organizations Market, 2020 - 2027(USD Million)
34. Rest of Asia-Pacific Contract Research Organizations Market, 2020 - 2027(USD Million)
35. Middle East & Africa Contract Research Organizations Market, 2020 - 2027(USD Million)
36. Middle East & Africa Contract Research Organizations Market share, by Countries, 2020 & 2027 (%)
37. GCC Contract Research Organizations Market, 2020 - 2027(USD Million)
38. South Africa Contract Research Organizations Market, 2020 - 2027(USD Million)
39. Rest Of Middle East & Africa Contract Research Organizations Market, 2020 - 2027(USD Million)
40. South America Contract Research Organizations Market, 2020 - 2027(USD Million)
41. Brazil Contract Research Organizations Market, 2020 - 2027(USD Million)
42. Mexico Contract Research Organizations Market, 2020 - 2027(USD Million)
43. Argentina Contract Research Organizations Market, 2020 - 2027(USD Million)
44. Rest Of South America Contract Research Organizations Market, 2020 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Contract Research Organizations Market, 2020-2027 (USD Million)
4. Contract Research Organizations requirement, by country, 2020-2027, (USD Million)
5. North America Contract Research Organizations Market, by Type, 2020-2027 (USD Million)
6. North America Contract Research Organizations Market, by Therapeutics area, 2020-2027 (USD Million)
7. Europe Contract Research Organizations Market, by Type, 2020-2027 (USD Million)
8. Europe Contract Research Organizations Market, by Therapeutics area, 2020-2027 (USD Million)
9. Asia Pacific Contract Research Organizations Market, by Type, 2020-2027 (USD Million)
10. Asia Pacific Contract Research Organizations Market, by Therapeutics area, 2020-2027 (USD Million)
11. Middle East & Africa Contract Research Organizations Market, by Type, 2020-2027 (USD Million)
12. Middle East & Africa Contract Research Organizations Market, by Therapeutics area, 2020-2027 (USD Million)
13. South America Contract Research Organizations Market, by Type, 2020-2027 (USD Million)
14. South America Contract Research Organizations Market, by Therapeutics area, 2020-2027 (USD Million)
15. Global Contract Research Organizations Market, Company Market Share, 2018 (%)
16. IQVIA: Product Benchmarking
17. IQVIA: Financial Performance
18. Clinipace: Product Benchmarking
19. Clinipace: Financial Performance
20. Charles River Laboratories International: Product Benchmarking
21. Charles River Laboratories International: Financial Performance
22. PRA Health Sciences: Product Benchmarking
23. PRA Health Sciences: Financial Performance
24. CMIC Holdings: Product Benchmarking
25. CMIC Holdings: Financial Performance
26. Synteract: Product Benchmarking
27. Synteract: Financial Performance
28. Medpace: Product Benchmarking
29. Medpace: Financial Performance
30. Parexel International: Product Benchmarking
31. Parexel International: Financial Performance
32. EPS International: Product Benchmarking
33. EPS International: Financial Performance
34. ICON : Product Benchmarking
35. ICON: Financial Performance

The Leading Key Players in Contract Research Organizations Market

IQVIA
Clinipace
Charles River Laboratories International
CMIC Holdings
Medpace
Parexel International
EPS International
ICON
PRA Health Sciences and Synteract